| 0 | 💬 0 |
CDK8 remodels the tumor microenvironment and promotes resistance to KRAS(G12D) inhibitors and daraxonrasib in PDAC.
(link.springer.com)
|
The EMBO Journal 2026-07-11 | #transcriptomics #pdac #immunotherapy #amr #proteomics |